Pharmacovigilance AND Drug Safety Software Market Presenting A CAGR OF 6.5% For The Forecast Period From 2018 To 2024 : Grand View Research Inc.
San Francisco, 25 July 2019: The Report Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical & Biotech Companies, CROs, BPOs), And Segment Forecasts, 2018 – 2024 The global pharmacovigilance and drug safety software market size is expected to reach USD 207.7 million by 2024, according to a new report by Grand View Research, Inc., presenting a CAGR of 6.5% during the forecast period. Increasing number of adverse drug reactions (ADR) is a key factor for market growth. ADR imposes a significant burden on research organizations and companies. To curb this problem, pharmaceutical companies are opting for contract outsourcing of these services. Manufacturers are now striving to identify various ways of cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service provid